This inventor holds 1 USPTO granted patent. Top assignee: University Patents, Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Cheryl Grosshans: Innovator in RNA Research
Introduction
Cheryl Grosshans is a prominent inventor based in Denver, CO (US). She has made significant contributions to the field of molecular biology, particularly in the area of RNA research. Her innovative work has led to the development of new methods and tools that enhance our understanding of RNA functions.
Latest Patents
Cheryl Grosshans holds a patent for "RNA ribozyme restriction endoribonucleases and methods." This patent describes new RNA endoribonuclease ribozymes that are discovered under specific conditions to prevent mismatch cleavage. These ribozymes are capable of cleaving RNA after six different sets of ribonucleotide four-base sequences. This advancement has important implications for genetic research and therapeutic applications.
Career Highlights
Cheryl Grosshans is associated with University Patents, Inc., where she continues her research and development efforts. Her work has been recognized for its innovative approach and potential impact on the scientific community. With a focus on RNA technologies, she has positioned herself as a key figure in this specialized field.
Collaborations
Cheryl has collaborated with notable scientists, including Thomas R. Cech and Felicia L. Murphy. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in RNA research.
Conclusion
Cheryl Grosshans is a trailblazer in RNA research, with her patent and collaborations highlighting her contributions to the field. Her work continues to inspire future innovations in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
